212 related articles for article (PubMed ID: 12851485)
21. Differential regulation of E2F1 apoptotic target genes in response to DNA damage.
Pediconi N; Ianari A; Costanzo A; Belloni L; Gallo R; Cimino L; Porcellini A; Screpanti I; Balsano C; Alesse E; Gulino A; Levrero M
Nat Cell Biol; 2003 Jun; 5(6):552-8. PubMed ID: 12766778
[TBL] [Abstract][Full Text] [Related]
22. Steroid- and retinoid-mediated growth arrest and apoptosis in WEHI-231 cells: role of NF-kappaB, c-Myc and CKI p27(Kip1).
Donjerković D; Mueller CM; Scott DW
Eur J Immunol; 2000 Apr; 30(4):1154-61. PubMed ID: 10760805
[TBL] [Abstract][Full Text] [Related]
23. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
[TBL] [Abstract][Full Text] [Related]
24. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation.
Hou ST; Cowan E; Walker T; Ohan N; Dove M; Rasqinha I; MacManus JP
J Neurochem; 2001 Jul; 78(2):287-97. PubMed ID: 11461964
[TBL] [Abstract][Full Text] [Related]
25. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
Chen Q; Hung FC; Fromm L; Overbeek PA
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
[TBL] [Abstract][Full Text] [Related]
26. Engineering the response to vascular injury: divergent effects of deregulated E2F1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growth.
Goukassian DA; Kishore R; Krasinski K; Dolan C; Luedemann C; Yoon YS; Kearney M; Hanley A; Ma H; Asahara T; Isner JM; Losordo DW
Circ Res; 2003 Jul; 93(2):162-9. PubMed ID: 12829616
[TBL] [Abstract][Full Text] [Related]
27. p19ARF targets certain E2F species for degradation.
Martelli F; Hamilton T; Silver DP; Sharpless NE; Bardeesy N; Rokas M; DePinho RA; Livingston DM; Grossman SR
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4455-60. PubMed ID: 11274364
[TBL] [Abstract][Full Text] [Related]
28. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
29. Oncogenes induce and activate endogenous p73 protein.
Zaika A; Irwin M; Sansome C; Moll UM
J Biol Chem; 2001 Apr; 276(14):11310-6. PubMed ID: 11115495
[TBL] [Abstract][Full Text] [Related]
30. The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation.
Dilla T; Romero J; Sanstisteban P; Velasco JA
Oncogene; 2002 Apr; 21(15):2376-86. PubMed ID: 11948421
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
[TBL] [Abstract][Full Text] [Related]
35. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
36. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
37. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.
Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS
Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.
Fogal V; Hsieh JK; Royer C; Zhong S; Lu X
EMBO J; 2005 Aug; 24(15):2768-82. PubMed ID: 16037820
[TBL] [Abstract][Full Text] [Related]
39. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
40. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
